Table 1.
References | Samples | Subjects | Carnitine | Positive or negative | Main results | Depression scales or ways used |
---|---|---|---|---|---|---|
Zhang et al. (29) | Plasma and urine | Control: n = 11; excess fatigue: n = 11; depression: n = 11 | C3:0, C4:0 | + | C3:0 and C4:0 in the overtired and depressed rats were lower than the control group. | Tail-hanging test |
Chen et al. (30) | Plasma | Control: n = 12; depression: n = 12; Alliummacrostemon-treated depression: n = 11 | Carnitine and ACs (C10:1, C12:0, C14:2, C14:1, C14:0, C16:2, C16:1, C16:0, C18:2, C18:1, C18:0, C20:2, C20:1, C20:0, C14:0-OH, C16:1-OH, C16:0-OH, C18:2-OH, C18:1-OH) | + | Most medium-chain and long-chain ACs (C10:1, C12:0, C14:2, C14:1, C14:0, C16:2, C16:1, C16:0, C18:2, C18:1, C18:0, C20:2, C20:1, C20:0, C14:0-OH, C16:1-OH, C16:0-OH, C18:2-OH, C18:1-OH) increased in the depression group. After treatment, most of the ACs decreased to the normal level, except for the C18:2-OH, C18:2, C20:2, but the three ACs also showed a significant tendency to the normal level. | Tail suspension test |
Zhao et al. (31) | Plasma | Control: n = 8; CUMS: n = 8; fluoxetine treatment: n = 8 | LAC and carnitine | – | The concentrations of LAC and carnitine in the model group were significantly higher than those in the control group, but there was no significant difference in the concentrations of carnitine and LAC between the fluoxetine treatment group and the model group. | Sucrose consumption |
Cm:n, Carnitine, in which “m” is the number of carbon atoms, “n” is the unsaturation. -OH represents hydroxylation, such as C18:1-OH = 3-hydroxy octadecenoyl carnitine.
ACs, acylcarnitines; CUMS, chronic unpredictable mild stress; LAC, acetyl-L-carnitine.